ReviewFrontiers in medicine2021

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease.

Juqiang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.